SR

Sanjay Ramesh Rawal

Active Director Additional Director DIN 10752057
DIN 10752057 First appointment Aug 2024 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Ramesh Rawal

Data last updated:

Sanjay Ramesh Rawal is an Additional Director at Healfirst Biosolutions Private Limited (since 2024). The company operates in Life Sciences.

DIN 10752057
Primary Designation Additional Director
Industry Life Sciences
First Appointment 26 Aug 2024
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director26 Aug 20242011Active

Directorship timeline

Open interactive timeline →
Healfirst Biosolutions Private Limited
Premium access

Shareholding and investment profile for Sanjay Ramesh Rawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Ramesh Rawal

Sanjay Ramesh Rawal currently holds 1 directorship: Healfirst Biosolutions Private Limited (Additional Director, since 26 Aug 2024).

Sanjay Ramesh Rawal was first appointed on 26 Aug 2024 as Additional Director at Healfirst Biosolutions Private Limited.

The current boards of Sanjay Ramesh Rawal's companies include Pradnya Hasmukh Rawal (Healfirst Biosolutions Private Limited), Pratima Shailendra Kawade (Healfirst Biosolutions Private Limited), Rajkumar Himmatsingh Suryavanshi (Healfirst Biosolutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available